A novel event-free survival endpoint in locally advanced pancreatic cancer

The treatment paradigm for locally advanced pancreatic cancer (LAPC) is evolving rapidly. The development of neoadjuvant therapies composed of combination therapies and the evaluation of their impact on conversion to borderline resectable (BR) status, resection, and ultimately overall survival (OS)...

Descripción completa

Detalles Bibliográficos
Autores principales: Hammel, Pascal, Carrier, Ewa, Carney, Mairead, Eisner, Mark, Fleming, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640304/
https://www.ncbi.nlm.nih.gov/pubmed/34868352
http://dx.doi.org/10.1177/17588359211059586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640304/
https://www.ncbi.nlm.nih.gov/pubmed/34868352
http://dx.doi.org/10.1177/17588359211059586

Ejemplares similares